A single CRISPR infusion lowers blood fats in monkeys for three years
High levels of LDL cholesterol and triglycerides, which are types of blood fats, are major contributors to atherosclerotic cardiovascular disease. Gene-editing technologies offer a potential alternative to lipid-lowering medications. In a new CRISPR experiment, a single infusion of a gene-editing treatment kept triglyceride levels low in monkeys for three years. The findings support the…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
